As the second day of AGBT came to a close, Julianna LeMieux, PhD, Deputy Editor in Chief at GEN, chatted with Kevin Davies, PhD, GEN‘s Editorial Director, about some of the biggest announcements from the day.
Next-generation sequencing (NGS) created the most excitement on day two, with lunch talks by both Roche and Ultima Genomics.
Ultima, a relative newcomer to the field, emphasized that they are driving big projects: single cell with the Billion Cells Project (with Chan Zuckerberg Initiative (CZI) and 10x Genomics) and the world’s largest and most comprehensive proteomics study to date (together with Olink and the UK biobank.)
Roche generated buzz last week when it first unveiled its new technology and instrument during a webinar. More information has been shared since then, with the posting of a preprint on bioRxiv and presenting customer data during their lunch talk at the meeting.
For more of AGBT coverage watch Dr. LeMieux’s first day recap.
